Fig. 14From: Emerging biomaterials for tumor immunotherapyMacroporous SF microsphere-based vaccines for tumor immunotherapy. A Schematic diagram of injectable macroporous SF microsphere-based vaccines. (a) Preparation of macroporous SF microsphere-based vaccines. (b) Mechanism of the vaccine in triggering tumor-specific immune responses to kill tumors. B The antitumor capacity of SFOCG vaccine. (a) The scheme of SFOCG inhibiting B16F10-OVA tumor. (b) Tumor growth and (c) body weight of the mice bearing B16F10-OVA tumors. (d) H&E staining and TUNEL staining of B16F10-OVA tumors in the mice at day 18. (Reproduced with permission from [115] Copyright © 2022, American Chemical Society)Back to article page